BGM
Qilian International Holding Group LimitedNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$115.51M
P/E Ratio
—
EPS
$-4.83
Beta
1.46
52W High
$303.00
52W Low
$6.45
50-Day MA
$8.47
200-Day MA
$24.91
Dividend Yield
—
Profit Margin
-44.20%
Forward P/E
—
PEG Ratio
—
About Qilian International Holding Group Limited
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company is headquartered in Jiuquan, the People's Republic of China.
Fundamentals
| Revenue (TTM) | $47.90M |
| Gross Profit (TTM) | $8.11M |
| EBITDA | $-9.25M |
| Operating Margin | -3.61% |
| Return on Equity | -7.41% |
| Return on Assets | -2.18% |
| Revenue/Share (TTM) | $7.55 |
| Book Value | $59.55 |
| Price-to-Book | 0.26 |
| Price-to-Sales (TTM) | 2.41 |
| EV/Revenue | 1.914 |
| EV/EBITDA | -2.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 69.80% |
| Shares Outstanding | $12.69M |
| Float | $4.59M |
| % Insiders | 38.05% |
| % Institutions | 0.10% |
Historical Volatility
HV 10-Day
97.36%
HV 20-Day
96.01%
HV 30-Day
84.25%
HV 60-Day
83.68%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BGM and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 10/17/2026